NASDAQ:BNR Burning Rock Biotech Q3 2026 Earnings Date & Estimates $13.51 +0.85 (+6.71%) Closing price 10/21/2026 04:00 PM EasternExtended Trading$13.64 +0.13 (+0.93%) As of 10/21/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Burning Rock Biotech is estimated to report Q3 2026 earnings on Tuesday, November 17, 2026. The conference call is scheduled for November 20, 2026 at 12:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 17, 2026Conference Call DateNovember 20, 2026Conference Call12:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Burning Rock Biotech in Q3 2026Burning Rock Biotech is expected to post earnings of -$2.2876 per share on revenue of $19.20 million. Burning Rock Biotech last reported on September 10, 2026, posting -$0.20 per share and beating the -$2.2883 consensus estimate.Consensus EstimatesConsensus EPS-$2.2876Expected Revenue$19.20 millionRecent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.20 (Beat by +$2.0883)Last Quarter Revenue$19.84 millionPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Burning Rock Biotech Q3 2026 Earnings FAQ When does Burning Rock Biotech report Q3 2026 earnings? Burning Rock Biotech (NASDAQ:BNR) is estimated to report Q3 2026 earnings on Tuesday, November 17, 2026. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Burning Rock Biotech's Q3 2026 earnings call? Burning Rock Biotech's Q3 2026 earnings conference call is scheduled for Friday, November 20, 2026 at 12:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Burning Rock Biotech? Analysts expect Burning Rock Biotech to post earnings of -$2.2876 per share for Q3 2026. How much revenue is Burning Rock Biotech expected to report? The consensus revenue estimate for Burning Rock Biotech is $19.20 million for Q3 2026. Burning Rock Biotech Earnings HeadlinesBurning Rock Biotech Ltd (BNR) Shares Surge 3.3% -- What GF Score of 53 Tells InvestorsSeptember 25, 2026 | gurufocus.comBurning Rock Q2 Revenue Falls 9%; In-Hospital Business Posts GrowthSeptember 10, 2026 | rttnews.comThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before they ever place a trade. This free guide from Base Camp Trading takes a different approach, starting with the basics and showing you exactly how options work, why traders use them, and how they fit into a simple trading plan. | Base Camp Trading (Ad)Burning Rock Biotech Limited: Burning Rock Reports Second Quarter 2026 Financial ResultsSeptember 10, 2026 | finanznachrichten.deBurning Rock Reports Second Quarter 2026 Financial ResultsSeptember 10, 2026 | globenewswire.comBurning Rock Biotech Corporate Event Calendar | NASDAQ:BNRJuly 10, 2026 | benzinga.comSee More Burning Rock Biotech Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Burning Rock Biotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Burning Rock Biotech and other key companies, straight to your email. Email Address About Burning Rock BiotechBurning Rock Biotech (NASDAQ:BNR) Limited is a China-based biotechnology company focused on precision oncology. The company develops and commercializes cancer testing products based primarily on next-generation sequencing and liquid biopsy technologies, which analyze tumor-related genetic material found in blood and other biological samples. Its activities span the cancer-care process, including early cancer detection, diagnosis, treatment selection and disease monitoring. Burning Rock provides testing solutions intended to help healthcare professionals identify cancer-associated mutations, assess patients’ potential responses to targeted therapies and monitor treatment outcomes or disease recurrence. It also offers testing and related services for pharmaceutical companies conducting oncology drug development and clinical research. Founded in 2014 and headquartered in Guangzhou, China, Burning Rock has built its business around serving hospitals, physicians, pharmaceutical companies and research institutions. The company’s commercial operations have primarily focused on the Chinese market, while its research and development activities support broader applications of precision medicine in oncology. Burning Rock’s American depositary shares began trading on the Nasdaq under the symbol BNR in 2020.View Burning Rock Biotech ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles SpaceX Earnings Launch: High Margins Fund AI AmbitionsGM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?Synchrony Aces The Quarter As Credit Fears FadeHigher Rates Are Sending Investors to These 3 Dividend KingsServiceNow Orchestrates AI's Next Act—Can Earnings Deliver?Swiping to Record Highs: Why Visa Remains a FortressDrone Stocks Have Burned Investors—Are These 4 Different? Upcoming Earnings ENI (10/23/2026)SLB (10/23/2026)American Express (10/23/2026)Infosys (10/23/2026)Verizon Communications (10/26/2026)Nucor (10/26/2026)Public Storage (10/26/2026)Welltower (10/26/2026)Cadence Design Systems (10/26/2026)Hilton Worldwide (10/27/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
